A detailed history of Granite Investment Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Granite Investment Partners, LLC holds 90,465 shares of ABBV stock, worth $16.3 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares
90,465
Previous 90,843 0.42%
Holding current value
$16.3 Million
Previous $15.6 Million 14.66%
% of portfolio
0.79%
Previous 0.67%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$163.84 - $199.33 $61,931 - $75,346
-378 Reduced 0.42%
90,465 $17.9 Million
Q2 2024

Aug 12, 2024

SELL
$154.79 - $180.76 $313,914 - $366,581
-2,028 Reduced 2.18%
90,843 $15.6 Million
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $346,010 - $394,246
-2,165 Reduced 2.28%
92,871 $16.9 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $168,009 - $189,218
-1,221 Reduced 1.27%
95,036 $14.7 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $157,769 - $182,641
1,181 Added 1.24%
96,257 $14.3 Million
Q2 2023

Aug 07, 2023

BUY
$132.51 - $164.9 $1.9 Million - $2.36 Million
14,333 Added 17.75%
95,076 $12.8 Million
Q1 2023

May 03, 2023

BUY
$144.61 - $166.54 $7.64 Million - $8.8 Million
52,812 Added 189.08%
80,743 $12.9 Million
Q4 2022

Feb 10, 2023

SELL
$138.31 - $165.87 $177,313 - $212,645
-1,282 Reduced 4.39%
27,931 $4.52 Million
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $2,685 - $3,398
25 Added 0.09%
29,213 $3.96 Million
Q2 2021

Jul 30, 2021

BUY
$105.21 - $117.21 $72,594 - $80,874
690 Added 2.42%
29,188 $3.29 Million
Q1 2021

May 13, 2021

BUY
$102.3 - $112.62 $99,742 - $109,804
975 Added 3.54%
28,498 $3.08 Million
Q2 2020

Aug 03, 2020

SELL
$73.37 - $98.18 $16,141 - $21,599
-220 Reduced 0.79%
27,523 $2.7 Million
Q1 2020

May 14, 2020

SELL
$64.5 - $97.79 $193,500 - $293,370
-3,000 Reduced 9.76%
27,743 $2.11 Million
Q2 2019

Aug 07, 2019

BUY
$65.7 - $83.98 $21,352 - $27,293
325 Added 1.07%
30,743 $2.24 Million
Q1 2019

May 13, 2019

SELL
$77.14 - $90.79 $57,855 - $68,092
-750 Reduced 2.41%
30,418 $2.45 Million
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $309,064 - $381,159
-3,970 Reduced 11.3%
31,168 $2.87 Million
Q3 2018

Nov 08, 2018

SELL
$88.91 - $98.84 $80,019 - $88,956
-900 Reduced 2.5%
35,138 $3.32 Million
Q2 2018

Aug 06, 2018

SELL
$89.78 - $106.23 $32,679 - $38,667
-364 Reduced 1.0%
36,038 $3.34 Million
Q1 2018

May 04, 2018

BUY
$92.01 - $123.21 $13,801 - $18,481
150 Added 0.41%
36,402 $3.45 Million
Q4 2017

Feb 01, 2018

SELL
$89.56 - $98.21 $133,444 - $146,332
-1,490 Reduced 3.95%
36,252 $3.51 Million
Q3 2017

Nov 08, 2017

BUY
$69.85 - $89.22 $2.64 Million - $3.37 Million
37,742
37,742 $3.35 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Granite Investment Partners, LLC Portfolio

Follow Granite Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Investment Partners, LLC with notifications on news.